Warraich, H. J., King, B. A., Compton, W. M., Herrmann, E. S., Hai, M. T., Califf, R. M., & Bertagnolli, M. M. (2025). Opportunities for Innovation in Smoking Cessation Therapies: A Perspective From the National Institutes of Health and U.S. Food and Drug Administration. Ann Intern Med, 178(1), 122–125. https://doi.org/10.7326/ANNALS-24-02318

Warraich, Haider J., Brian A. King, Wilson M. Compton, Evan S. Herrmann, Mary Thanh Hai, Robert M. Califf, and Monica M. Bertagnolli. “Opportunities for Innovation in Smoking Cessation Therapies: A Perspective From the National Institutes of Health and U.S. Food and Drug Administration.” Ann Intern Med 178, no. 1 (January 2025): 122–25. https://doi.org/10.7326/ANNALS-24-02318.

Warraich HJ, King BA, Compton WM, Herrmann ES, Hai MT, Califf RM, et al. Opportunities for Innovation in Smoking Cessation Therapies: A Perspective From the National Institutes of Health and U.S. Food and Drug Administration. Ann Intern Med. 2025 Jan;178(1):122–5.

Warraich, Haider J., et al. “Opportunities for Innovation in Smoking Cessation Therapies: A Perspective From the National Institutes of Health and U.S. Food and Drug Administration.” Ann Intern Med, vol. 178, no. 1, Jan. 2025, pp. 122–25. Pubmed, doi:10.7326/ANNALS-24-02318.

Warraich HJ, King BA, Compton WM, Herrmann ES, Hai MT, Califf RM, Bertagnolli MM. Opportunities for Innovation in Smoking Cessation Therapies: A Perspective From the National Institutes of Health and U.S. Food and Drug Administration. Ann Intern Med. 2025 Jan;178(1):122–125.